Clinical Trials Logo

Clinical Trial Summary

This is a pilot randomised control trial to assess the safety, compliance, and acceptability of delivering a 6-week programme of remote ischaemic conditioning (RIC) to stroke patients suffering with fatigue, and study feasibility. A minimum of 34 patients who have suffered an ischeamic or haemorrhagic stroke and who suffer from fatigue, will be recruited and randomised to receive a 6-week programme of either RIC or a sham intervention.


Clinical Trial Description

Up to 75% of stroke patients suffer from fatigue, the effect of which can be physical, cognitive or emotional, and presents a large barrier to progressing rehabilitation.

Remote ischaemic conditioning (RIC) is a procedure whereby ischaemia is induced to a limb for short periods of time by inflating pressure cuffs around arms or legs to above systolic pressures (mmHg). This procedure is performed for periods that avoid physical injury to the limbs, but induce neurohormonal, systemic or vascular changes in the body. Such changes often result in improved collateralisation of blood supply to various areas of the body, as well as improved efficiencies of cellular metabolism. This may enhance the physical abilities of patients undergoing rehabilitation after stroke, particularly when aiming to improve endurance and fatigue. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03794947
Study type Interventional
Source Sheffield Teaching Hospitals NHS Foundation Trust
Contact Alessia Dunn
Phone 0114 271 2550
Email Alessia.Dunn@sth.nhs.uk
Status Not yet recruiting
Phase N/A
Start date January 1, 2019
Completion date November 1, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Active, not recruiting NCT02911649 - Reducing Sedentary Behaviour With Technology N/A
Recruiting NCT02321358 - Trial of a Behavior Change Intervention to Increase Aerobic and Resistance Exercise and Quality of Life in Older Prostate and Breast Cancer Survivors N/A
Completed NCT03216616 - Guided Self-Management Intervention Targeting Fatigue in Rheumatic Inflammatory Diseases N/A
Completed NCT01744678 - Fatigue Countermeasure Program in Operational Flight Controllers N/A
Completed NCT01919853 - Treatment for Persistently Fatigued Cancer Survivors: A Randomized Controlled Trial With Biomarker Response Phase 2
Terminated NCT01740154 - Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer N/A
Completed NCT01707095 - Bundling and Unbundling the Laparoscopic Electrosurgery Cord With the Camera Cord N/A
Not yet recruiting NCT01228006 - Study for Effectiveness Evaluation of Panax Ginseng, Vitamins and Minerals (Natugerin®) in Improvement of Stress and Fatigue Phase 3
Completed NCT01407770 - Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Completed NCT01444300 - Dalfampridine for Imbalance in Multiple Sclerosis Phase 2
Terminated NCT01572168 - Acupuncture for the Treatment of Cancer Related Fatigue Phase 2
Recruiting NCT01097317 - First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer Phase 2
Completed NCT00924651 - Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy Phase 3
Completed NCT00775645 - S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy Phase 3
Completed NCT00997269 - Benefit of CoQ-10 in Patients on Statins N/A
Completed NCT00866970 - Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia Phase 2
Completed NCT00772226 - The Use of Music as Pain Therapy in Patients Undergoing Laparoscopic Cholecystectomy in a Day Care Unit Phase 3
Completed NCT01767922 - Multicentre, Double-blind Study Versus Placebo on Impact and Safety of Extramel® 140 IU on Perceived Stress, Physical and Intellectual Fatigue, Pain Perception if Present, and the Impact on the Quality of Life Phase 3
Completed NCT00959998 - Acupressure for Post-Treatment Cancer Fatigue Phase 2